Vertex Pharmaceuticals (VRTX) Restructuring Costs (2009 - 2018)

Vertex Pharmaceuticals' Restructuring Costs history runs 10 years deep, the most recent figure standing at -$4000.0 for Q4 2018.

• In Q4 2018, Restructuring Costs fell 101.03% year-over-year to -$4000.0; the TTM figure through Sep 2019 stood at -$4000.0 (down 100.7% YoY), while the FY2018 annual figure was -$184000.0, down 101.29% from the prior year.
• Restructuring Costs was -$4000.0 for Q4 2018 at Vertex Pharmaceuticals, down from $174000.0 in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $40.8 million in Q3 2014 to a low of -$3.3 million in Q1 2015.
• Historically, Restructuring Costs has averaged $3.4 million across 5 years, with a median of $365000.0 in 2016.
• The sharpest annual moves came in 2014 and 2015: Restructuring Costs jumped 15766.67% in 2014, then slumped 152.88% in 2015.
• A 5-year view of Restructuring Costs shows it stood at $4.2 million in 2014, then slumped by 63.4% to $1.5 million in 2015, then plunged by 85.3% to $224000.0 in 2016, then jumped by 72.77% to $387000.0 in 2017, then tumbled by 101.03% to -$4000.0 in 2018.
• The last three Restructuring Costs figures came in at -$4000.0 (Q4 2018), $174000.0 (Q3 2018), and -$62000.0 (Q2 2018), per Business Quant data.